Earnings Call · Q1 FY2025·2025-05-13

Q1 25EPS +31.08%·Rev n/aQ4 24EPS +27.88%·Rev n/aQ3 24EPS +21.24%·Rev n/aQ2 24EPS -8.18%·Rev n/a⚠ consensus missing

INOVIO PHARMACEUTICALS, INC. INO

Jennie Willson — Investor Relations or Communications

Jacqui Shea — President and Chief Executive Officer

Mike Sumner — Chief Medical Officer

Steve Egge — Chief Commercial Officer

Peter Kies — Chief Financial Officer

−1.0%1d on move date−1.7% vs SPY3d+0.5%5d+6.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more INO calls or request research access.

More INO calls Browse calls Request research access